CINECA IRIS Institutional Research Information System

MAIONE, Federica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.337
EU - Europa 2.323
AS - Asia 1.459
AF - Africa 37
OC - Oceania 18
SA - Sud America 14
Continente sconosciuto - Info sul continente non disponibili 8
Totale 7.196
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.273
IT - Italia 925
CN - Cina 918
IE - Irlanda 226
FR - Francia 187
GB - Regno Unito 163
DE - Germania 158
SE - Svezia 158
SG - Singapore 129
FI - Finlandia 100
JP - Giappone 92
AT - Austria 74
UA - Ucraina 61
CA - Canada 58
PL - Polonia 58
VN - Vietnam 55
HK - Hong Kong 54
KR - Corea 53
IN - India 47
ES - Italia 35
BE - Belgio 34
IL - Israele 31
CH - Svizzera 29
TW - Taiwan 29
SN - Senegal 26
NL - Olanda 24
DK - Danimarca 21
AU - Australia 14
TR - Turchia 13
HU - Ungheria 12
RU - Federazione Russa 12
GR - Grecia 11
RO - Romania 8
EU - Europa 7
AE - Emirati Arabi Uniti 6
CZ - Repubblica Ceca 6
IR - Iran 6
MX - Messico 6
ZA - Sudafrica 6
BR - Brasile 5
PT - Portogallo 5
AR - Argentina 4
NZ - Nuova Zelanda 4
AM - Armenia 3
CO - Colombia 3
ID - Indonesia 3
IQ - Iraq 3
LT - Lituania 3
MY - Malesia 3
NO - Norvegia 3
PK - Pakistan 3
TH - Thailandia 3
AL - Albania 2
CL - Cile 2
DZ - Algeria 2
HR - Croazia 2
KW - Kuwait 2
LB - Libano 2
LU - Lussemburgo 2
NG - Nigeria 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CY - Cipro 1
GH - Ghana 1
IS - Islanda 1
PS - Palestinian Territory 1
SI - Slovenia 1
Totale 7.196
Salva come PNG Salva come JPEG
Città #
Chandler 346
Ann Arbor 320
Torino 253
Fairfield 246
Beijing 242
Dublin 225
Houston 167
Ashburn 140
Seattle 119
Woodbridge 118
Wilmington 107
Cambridge 98
Dearborn 94
Shanghai 93
Redwood City 83
Villeurbanne 82
Guangzhou 79
Singapore 77
Nyköping 74
Vienna 72
Pisa 65
Turin 65
Milan 61
Princeton 59
Jacksonville 58
Medford 58
Nanjing 43
Warsaw 42
Fremont 38
Hangzhou 38
Dong Ket 33
Rome 32
Tokyo 29
Wuhan 28
Boston 27
Los Angeles 26
San Diego 25
London 22
Brussels 21
San Francisco 19
Boardman 17
Chengdu 17
Helsinki 17
Taipei 17
Xian 17
New York 16
Changsha 15
Paris 15
Jinan 14
Phoenix 14
Central 13
Chongqing 13
Dallas 13
Munich 13
Santa Clara 13
Central District 11
Hefei 11
Norwalk 11
Ottawa 11
Silver Spring 11
Tianjin 11
Zhengzhou 11
Chicago 10
Herzliya 10
New Haven 10
Frankfurt am Main 9
Luni 9
Menlo Park 9
Palermo 9
Pittsburgh 9
Simi Valley 9
Trieste 9
Duncan 8
Rehovot 8
Sassari 8
Shenzhen 8
Toronto 8
Barcelona 7
Bethesda 7
Birmingham 7
Cincinnati 7
Créteil 7
Falls Church 7
Fuzhou 7
Genoa 7
Hebei 7
Lanzhou 7
Pune 7
Toulouse 7
Zurich 7
Bari 6
Guiyang 6
Hong Kong 6
Irvine 6
Krakow 6
Kunming 6
Lyngby 6
Madrid 6
Marietta 6
Melbourne 6
Totale 4.409
Salva come PNG Salva come JPEG
Nome #
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth 1.792
A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent 621
Nucleolin targeting impairs the progression of pancreatic cancer and promotes the normalization of tumor vasculature 232
Activation of P2X7 and P2Y11 purinergic receptors inhibits migration and normalizes tumor-derived endothelial cells via cAMP signaling 218
Activation of P2X7 and P2Y11 purinergic receptors inhibits migration and normalizes tumor-derived endothelial cells via cAMP signaling. 197
The cholesterol biosynthesis enzyme oxidosqualene cyclase is a new target to impair tumour angiogenesis and metastasis dissemination 190
Proteomics-based metabolic modelling reveals that fatty acid oxidation controls endothelial cell permeability. 188
Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor. 182
Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice 164
Targeting oncogenic serine/threonine-protein kinase BRAF in cancer cells inhibits angiogenesis and abrogates hypoxia 155
α-ketoglutarate dehydrogenase inhibition counteracts breast cancer-associated lung metastasis 153
Albumin nanoformulations as an innovative solution to overcome doxorubicin chemoresistance 152
Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity 148
SILAC-based proteomics of human primary endothelial cell morphogenesis unveils tumor angiogenic markers 146
Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform. 142
Class 3 semaphorins in cardiovascular development 131
CAR T cells targeting tumor endothelial marker CLEC14A inhibit tumor growth 111
Sema3F (Semaphorin 3F) Selectively Drives an Extraembryonic Proangiogenic Program 108
Targeting the MET oncogene by concomitant inhibition of receptor and ligand via an antibody-“decoy” strategy 104
HIV-protease inhibitors impair angiogenesis and tumor progression by targeting MMP-9 in a transgenic mouse model of spontaneous cervical carcinogenesis 101
AP-2{alpha} and AP-2{gamma} regulate tumor progression via specific genetic programs 98
Class 3 semaphorins: physiological vascular normalizing agents for anti-cancer therapy 91
Semaphorin 3A blocks cancer invasiveness and metastases dissemination induced by theanti-angiogenic therapy by overcoming tumor hypoxia 87
Semaphorin 3A Regulates Angiogenesis and Tumor Progression in Mouse Models of Tumorigenesis 82
Semaphorin 3A blocks tumor invasion, inhibits metastases formation and prevents the resistance to the anti-angiogenic therapies by overcoming cancer hypoxia. 80
HIV-protease inhibitors block HPV16-induced murine cervical carcinoma and promote vessel normalization in association with MMP-9 inhibition and TIMP-3 induction 79
Semaphorin 4A Exerts a Proangiogenic Effect by Enhancing Vascular Endothelial Growth Factor-A Expression in Macrophages 78
Semaphorins and tumor angiogenesis 76
Tumor angiogenesis: methods to analyze tumor vasculature and vessel normalization in mouse models of cancer 73
Therapeutic Silencing of miR-214 Inhibits Tumor Progression in Multiple Mouse Models 69
Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects 67
Semaphorin 4A promotes VEGF-mediated angiogenesis in macrophages 66
Increased Expression of {alpha}6 Integrin in Endothelial Cells Unveils a Proangiogenic Role for Basement Membrane 64
Semaphorin 3A blocks tumor invasiveness and metastases formation induced by anti-angiogenic therapy by overcoming cancer hypoxia 63
Temozolomide drives mismatch repair deficiency and fosters neoantigen generation in tumor cells 63
Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects 60
HIV-protease inhibitor exert antiangiogenic and antitumor action by disregulating the balance between TIMPs and MMPs in cervical cancer 59
Semaphorin 3A is an endogenous angiogenesis inhibitor that blocks tumor growth and normalizes tumor vasculature in transgenic mouse models 59
HIV-protease inhibitors impair angiogenesis and tumor progression by targeting MMP-9 in a transgenic mouse model of spontaneous cervical carcinogenesis 57
Multivalent cationic pseudopeptide polyplexes as a tool for cancer therapy 57
Osteopontin binds ICOSL promoting tumor metastasis 57
Squalenic nanoparticles with active targeting: in vivo results 52
Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects. 51
Semaphorin 3A normalizes the tumor vasculature and impairs tumor progression in a Nrp-1-independent manner 50
Targeted nanoparticles for pancreatic cancer. 49
Targeted nanoparticles for pancreatic cancer. 47
Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor. 47
Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor 47
Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAFV600E Protein 44
NCL targeting impairs the progression of pancreatic ductal adenocarcinoma and promotes tumor vessel normalization through Ang-2 inhibition 44
Nanoparticles targeting pancreatic tumor. 43
The neuronal protein Neuroligin 1 promotes colorectal cancer progression by modulating the APC/β-catenin pathway 39
Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects. 36
Neuropilin-1 Identifies a Subset of Bone Marrow Gr1- Monocytes That Can Induce Tumor Vessel Normalization and Inhibit Tumor Growth 34
Design and synthesis of encorafenib-based BRAF-V600E degraders 27
Neuropilin 1 and its inhibitory ligand mini-tryptophanyl-tRNA synthetase inversely regulate VE-cadherin turnover and vascular permeability 25
Semaphorin 4A-expressing bone marrowderived myeloid cells promote tumor progression 15
Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression 14
Semaphorin 4A-expressing bone marrowderived myeloid cells promote tumor progression 11
Preclinical efficacy of carfilzomib in BRAF-mutant colorectal cancer models 10
Abstract 5723: Inactivation of DNA repair triggers neoantigen generation and impairs tumor growth 2
Abstract 2743: Accumulation of predicted neoantigens by MMR deficiency triggered by temozolomide treatment of human colorectal cancer 2
Totale 7.409
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.999
article - articoli 0
book - libri 0
conference - conferenze 5.085
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.084
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020899 0 0 42 111 73 146 85 93 105 115 76 53
2020/20211.203 63 59 43 86 142 105 94 72 109 134 125 171
2021/20221.322 106 109 85 114 84 100 78 91 79 90 235 151
2022/20231.374 113 124 52 113 119 299 120 84 125 58 102 65
2023/20241.004 85 131 77 91 79 70 74 89 26 72 95 115
2024/2025194 51 109 34 0 0 0 0 0 0 0 0 0
Totale 7.409